Azenta AZTA
NASDAQ AZTA
$38.75 +4.27 (+12.38%)
At close: Oct 2, 2026 · 4:00 PM EDT

Azenta (AZTA) Asset Writedowns and Impairment (2013 - 2026)

Updated

Azenta (AZTA) recorded Asset Writedowns and Impairment of $149.08 million in fiscal Q2 2026 (quarter ended Mar 31, 2026).

Analysis

Azenta (AZTA) Asset Writedowns and Impairment (2013 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Azenta reported Asset Writedowns and Impairment of $93.12 million.

  • Annual Asset Writedowns and Impairment has a four-year compound annual growth rate of 62.5% (FY2021 to FY2025).
  • Across earlier fiscal years, Asset Writedowns and Impairment came in at $3.29 million in FY2024 and $13.36 million in FY2021.
  • The fiscal Q2 2026 figure is the highest quarterly Asset Writedowns and Impairment in data going back to fiscal Q4 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Azenta 1.70 Bn 238.99 Mn 72.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 149.08 Mn
Dec 31, 2025 9.70 Mn
Sep 30, 2025 412,000.00
Sep 30, 2024 3.29 Mn
Sep 30, 2015 1.94 Mn
Sep 30, 2014 -2.22 Mn
Jun 30, 2014 2.62 Mn
Dec 31, 2013 398,000.00
Sep 30, 2013 1.96 Mn
API Access

Azenta Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=AZTA&period=max&api_key=YOUR_API_KEY